"Study Reveals Semaglutide Drugs Like Ozempic, Wegovy May Reduce Suicidal Thoughts, Despite FDA Scrutiny"
A study funded by the National Institutes of Health found that users of the diabetes and obesity drugs Wegovy and Ozempic, which contain semaglutide, had a significantly lower risk of suicidal thoughts compared to those on other medications for the same conditions. The research comes amid regulatory reviews of anecdotal reports linking semaglutide to self-harm thoughts. The study analyzed records from over 1.8 million patients and suggests a need for further investigation and longer-term patient monitoring. The findings are in line with Novo Nordisk's data, which has not shown a causal link between semaglutide and suicidal thoughts or self-harm.